WST

344.25

2.17% 7.31

Dopo l'orario di chiusura: 344.25

West Pharmaceutical Services Inc (WST)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché WST Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$336.94

Aprire:

$333.57

Volume 24 ore:

644.24K

Relative Volume:

0.96

Capitalizzazione di mercato:

$24.23B

Reddito:

$3.22B

Utile/perdita netta:

$542.70M

Rapporto P/E:

46.02

EPS:

7.4805

Flusso di cassa netto:

$458.00M

1 W Prestazione:

+0.44%

1M Prestazione:

-2.24%

6M Prestazione:

+47.22%

1 anno Prestazione:

+34.88%

Intervallo 1D:

$331.99

$344.92

Intervallo di 1 settimana:

$331.99

$344.92

Portata 52W:

$223.83

$386.00

West Pharmaceutical Services Inc Stock (WST) Company Profile

Nome

West Pharmaceutical Services Inc

Settore

Healthcare (1069)

Industria

Medical Instruments & Supplies (56)

Telefono

(610) 594-2900

Indirizzo

530 HERMAN O. WEST DRIVE, EXTON, PA

Dipendente

10,800

Cinguettio

@WestPharma

Prossima data di guadagno

2026-10-22

Ultimi documenti SEC

WST's Discussions on Twitter

Compare WST vs ISRG, BDX, ALC, RMD, MDLN

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
WST West Pharmaceutical Services Inc	344.25	23.71B	3.22B	542.70M	458.00M	7.4805
ISRG Intuitive Surgical Inc	360.46	124.79B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	176.42	48.98B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	66.55	33.08B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	219.58	31.73B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	32.39	29.87B	29.14B	1.07B	1.05B	1.1956

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-02	Iniziato	Morgan Stanley	Equal-Weight
2025-09-15	Iniziato	Rothschild & Co Redburn	Buy
2025-06-24	Iniziato	Barclays	Equal Weight
2025-03-18	Iniziato	Evercore ISI	Outperform
2025-02-14	Aggiornamento	Deutsche Bank	Hold → Buy
2025-01-08	Iniziato	Citigroup	Buy
2024-12-13	Iniziato	Wolfe Research	Peer Perform
2024-12-12	Aggiornamento	UBS	Neutral → Buy
2024-02-07	Aggiornamento	Jefferies	Hold → Buy
2023-06-16	Aggiornamento	BofA Securities	Neutral → Buy
2023-04-11	Aggiornamento	Stephens	Equal-Weight → Overweight
2022-12-14	Iniziato	Deutsche Bank	Hold
2022-11-30	Iniziato	UBS	Neutral
2022-10-28	Downgrade	BofA Securities	Buy → Neutral
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2020-10-14	Iniziato	Stephens	Equal-Weight
2020-07-21	Aggiornamento	BofA Securities	Neutral → Buy
2020-04-24	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-12-12	Downgrade	BofA/Merrill	Neutral → Underperform
2019-07-26	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-05-01	Downgrade	Jefferies	Buy → Hold
2019-04-23	Iniziato	William Blair	Outperform
2018-04-25	Downgrade	BofA/Merrill	Neutral → Underperform
2018-01-24	Iniziato	Goldman	Neutral
2017-10-17	Downgrade	BofA/Merrill	Buy → Neutral
2017-10-03	Iniziato	Stephens	Equal-Weight
2017-09-15	Aggiornamento	Jefferies	Hold → Buy
2016-10-28	Aggiornamento	Wells Fargo	Market Perform → Outperform
2016-09-21	Downgrade	Wells Fargo	Outperform → Market Perform
2016-03-22	Iniziato	Wells Fargo	Outperform
2010-05-14	Reiterato	UBS	Neutral
2010-02-23	Iniziato	Jefferies & Co	Buy
2008-12-19	Iniziato	UBS	Neutral

Mostra tutto

West Pharmaceutical Services Inc Borsa (WST) Ultime notizie

05:40 AM

West Pharmaceutical Services Sr. VP & Chief HR Officer Sold Shares Worth Over $2.7M - TradingView

05:40 AM

05:37 AM

West Pharmaceutical (NYSE: WST) HR chief sells stock outside a 10b5-1 plan - Stock Titan

05:37 AM

05:04 AM

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch

05:04 AM

03:40 AM

West Pharmaceutical (NYSE: WST) awards CEO 37K options and 14.8K RSUs vesting through 2031 - Stock Titan

03:40 AM

03:34 AM

West Pharmaceutical (NYSE: WST) CEO discloses initial 7,850-share stake - Stock Titan

03:34 AM

10:45 AM

COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down - Zacks Investment Research

10:45 AM

09:47 AM

West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts - Investing.com

09:47 AM

09:30 AM

West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts By Investing.com - Investing.com UK

09:30 AM

07:39 AM

West Pharmaceutical stock gains as UBS lifts price target to USD 415 - ad-hoc-news.de

07:39 AM

01:06 AM

West Pharmaceutical stock heads into the open after a 0.7 percent dip - ad-hoc-news.de

01:06 AM

Sep 08, 2026

West Pharmaceutical stock heads before the bell after a 0.8 percent drop - ad-hoc-news.de

Sep 08, 2026

West Pharmaceutical (NYSE:WST): Has the Growth Story Been Priced In? - Kalkine Media

Sep 08, 2026

Sep 07, 2026

West Pharmaceutical stock gains after strong Q2 figures - ad-hoc-news.de

Sep 07, 2026

Novocure Reports Patient Data Exposure in Cybersecurity Incident - TradingView

Sep 07, 2026

Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity? - Yahoo Finance

Sep 07, 2026

West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Potential 19% Upside in the Healthcare Sector - DirectorsTalk Interviews

Sep 07, 2026

Sep 05, 2026

Rubber Gaskets Pharmaceutical Containers Market Outlook to 2035 - IndexBox

Sep 05, 2026

Sep 04, 2026

West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap - Yahoo Finance

Sep 04, 2026

Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - TradingView

Sep 04, 2026

West Pharmaceutical Services stock holds steady as investors eye recent rating and earnings momentum - ad-hoc-news.de

Sep 04, 2026

Sep 03, 2026

West Pharma Sets September Investor Conference Appearances - MyChesCo

Sep 03, 2026

Sep 02, 2026

West Pharmaceutical (NYSE:WST) Draws Attention As Fair Value Rises - Kalkine Media

Sep 02, 2026

West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Sep 02, 2026

West Pharmaceutical stock gains on strong Q2 2026 earnings and guidance - ad-hoc-news.de

Sep 02, 2026

Sep 01, 2026

West Pharmaceutical stock holds above $340 as analysts target higher gains - AD HOC NEWS

Sep 01, 2026

Aug 31, 2026

West Pharmaceutical stock holds steady as analysts maintain a moderate buy view - AD HOC NEWS

Aug 31, 2026

West Pharmaceutical Services (WST): Investor Outlook with a Promising 19.93% Upside Potential - DirectorsTalk Interviews

Aug 31, 2026

Aug 28, 2026

Are Wall Street Analysts Predicting West Pharmaceutical Stock Will Climb or Sink? - webull.com

Aug 28, 2026

West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch

Aug 28, 2026

Aug 27, 2026

West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch

Aug 27, 2026